C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 211/49 (2006.01) A61K 31/04 (2006.01) A61K 31/05 (2006.01) A61K 31/085 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/36 (2006.01) C07C 211/29 (2006.01) C07C 215/46 (2006.01) C07C 217/54 (2006.01) C07C 233/43 (2006.01) C07C 243/02 (2006.01) C07D 317/58 (2006.01)
Patent
CA 2384094
Pharmaceutical compositions aryl substituted amine compounds, and in particular, 3-aminophenyl amine compounds are provided. Representative compounds are (4E)-N-methyl-5-(3-acetamido-4-methylphenyl)-4-penten-2-amine, (4E)-N-methyl-5-(3-amino-4-methylphenyl)-4-penten-2-amine, (4E)-N-methyl-5-(3- (dimethylamino)phenyl)-4-penten-2-amine, (4E)-N-methyl-5-(4-methyl-3- nitrophenyl)-4-penten-2-amine, (4E)-N-methyl-5-(3-fluorophenyl)-4-penten-2- amine, (4E)-N-methyl-5-(3,4-dichlorophenyl)-4-penten-2-amine and (4E)-N-methyl- 5-(3,4-methylenedioxyphenyl)-4-penten-2-amine.
Cette invention se rapporte à des compositions pharmaceutiques constituées par des composés amine à substitution aryle et en particulier par des composés 3-aminophényl-amine. Les composés représentatifs sont (4E)-N-méthyl-5-(3-acétamido-4-méthylphényl)-4-pentène-2-amine, (4E)-N-méthyl-5-(3-amino-4-méthylphényl)-4-pentène-2-amine, (4E)-N-méthyl-5-(3-(diméthylamino)phényl)-4-pentène-2-amine, (4E)-N-méthyl-5-(4-méthyl-3-nitrophényl)-4-pentène-2-amine, (4E)-N-méthyl-5-(3-fluorophényl)-4-pentène-2-amine, (4E)-N-méthyl-5-(3,4-dichlorophényl)-4-pentène-2-amine et (4E)-N-méthyl-5-(3,4-méthylènedioxyphényl)-4-pentène-2-amine.
Bhatti Balwinder Singh
Caldwell William Scott
Dull Gary Maurice
Hadimani Srishailkumar Basawannappa
Miller Craig Harrison
Bereskin & Parr
Targacept Inc.
LandOfFree
Pharmaceutical compositions and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2073927